Pharmaceutical companies in India are seeking larger product-liability insurance cover as they face an increase in compliance costs due to regulatory action by the U.S. Food and Drug Administration, reported Business Standard.
Pharmaceutical companies in India are seeking larger product-liability insurance cover as they face an increase in compliance costs due to regulatory action by the U.S. Food and Drug Administration, reported Business Standard.